Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590590 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal Discomfort
A Phase 2 study, sponsored by Lumara Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 105
- Enrollment target
NCT00590590 is a Phase 2 study that has completed, run by Lumara Health. The registered enrollment target is 105 participants.
The verdict
NCT00590590, a Phase 2 study, has completed, sponsored by Lumara Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 105 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy and safety of two vaginal products compared with that of placebo to determine if the two products are better than placebo in the relief of vaginal discomfort.
Interventions
- DRUG placebo
- DRUG lidocaine
- DRUG Lidocaine/Diphenhydramine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00590590
The ClinicalTrials.gov registry entry for NCT00590590 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumara Health, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00590590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00590590 about?
NCT00590590 is a clinical study titled "Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal Discomfort". This study will evaluate the efficacy and safety of two vaginal products compared with that of placebo to determine if the two products are better than placebo in the relief of vaginal discomfort.
What is the current status of trial NCT00590590?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2007-10. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00590590?
The interventions under investigation include: placebo (DRUG), lidocaine (DRUG), Lidocaine/Diphenhydramine (DRUG).
Who is sponsoring clinical trial NCT00590590?
This trial is sponsored by Lumara Health, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.